{
    "title": "Higher Vitamin D-binding protein is good (neonates in this case)",
    "slug": "higher-vitamin-d-binding-protein-is-good-neonates-in-this-case",
    "aliases": [
        "/Higher+Vitamin+D-binding+protein+is+good+neonates+in+this+case+\u2013+Feb+2023",
        "/14268"
    ],
    "tiki_page_id": 14268,
    "date": "2023-02-16",
    "categories": [
        "Infant-Child",
        "Vit D Binding Protein"
    ],
    "tags": [
        "CYPB",
        "IBD",
        "Infant-Child",
        "Vit D Binding Protein",
        "autoimmune",
        "autoimmune and pregnancy",
        "bipolar disorder",
        "brain",
        "cancer",
        "child",
        "childhood cancer",
        "childhood obesity",
        "cognitive",
        "dementia",
        "depression",
        "depression and pregnancy",
        "diabetes",
        "fertility sperm",
        "genetics",
        "gut",
        "health risk",
        "high dose",
        "immunity",
        "intervention",
        "life span",
        "metabolic",
        "mood disorders",
        "mortality",
        "multiple sclerosis",
        "multiple sclerosis and pregnancy",
        "neurological",
        "obesity",
        "obesity and cancer",
        "omega 3",
        "omega 3 and pregnancy",
        "pain",
        "pediatric autoimmune",
        "pregnancy",
        "rheumatoid arthritis",
        "therapeutic intervention",
        "type 1 diabetes",
        "vitamin d",
        "vitamin d binding",
        "vitamin d blood test"
    ]
}


{{< toc >}} 

---

#### Genetic correlates of vitamin D-binding protein and 25-hydroxyvitamin D in neonatal dried blood spots

.Nat Commun 2023 Feb 15;14(1):852. [doi: 10.1038/s41467-023-36392-5.](https://doi.org/10.1038/s41467-023-36392-5.)

Clara Albiñana 1, Zhihong Zhu 1, Nis Borbye-Lorenzen 2, Sanne Grundvad Boelt 2 3, Arieh S Cohen 4, Kristin Skogstrand 2, Naomi R Wray 5 6, Joana A Revez 5, Florian Privé 1, Liselotte V Petersen 1 7, Cynthia M Bulik 8 9 10, Oleguer Plana-Ripoll 1 11, Katherine L Musliner 12, Esben Agerbo 1 7 13, Anders D Børglum 7 14 15, David M Hougaard 7 16, Merete Nordentoft 7 17 18, Thomas Werge 7 19 20 21, Preben Bo Mortensen 1 7 13, Bjarni J Vilhjálmsson 1 7 22, John J McGrath 23 24 25

<img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/toc-binding.jpg" alt="image" width="450">

<img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/d-vs-binding.jpg" alt="image" width="450">

The Vitamin D binding protein (DBP), encoded by the group-specific component (GC) gene, is a component of the Vitamin D_system. In a genome-wide association study of DBP concentration in 65,589 neonates we identify 26 independent loci, 17 of which are in or close to the GC gene, with fine-mapping identifying 2 missense variants on chromosomes 12 and 17 (within SH2B3 and GSDMA, respectively). When adjusted for GC haplotypes, we find 15 independent loci distributed over 10 chromosomes. Mendelian randomization analyses identify a unidirectional effect of higher DBP concentration and (a) higher 25-hydroxyvitamin D concentration, and (b) a reduced risk of multiple sclerosis and rheumatoid arthritis. A phenome-wide association study confirms that higher DBP concentration is associated with a reduced risk of Vitamin D deficiency. Our findings provide valuable insights into the influence of DBP on Vitamin D status and a range of health outcomes.

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/binding-neonates-compresspdf.pdf">Download the PDF from VitaminDWiki </a>** 

 **Grant support** 

na/Danmarks Grundforskningsfond (Danish National Research Foundation)

R345-2020-1588/Lundbeckfonden (Lundbeck Foundation)

R102-A9118, R155-2014-1724, and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)

R276-2018-4581/Lundbeckfonden (Lundbeck Foundation)

R335-2019-2339/Lundbeckfonden (Lundbeck Foundation)

---

##### Study references

1. Bouillon, R., Schuit, F., Antonio, L. & Rastinejad, F.  **Vitamin D**  **binding**  protein: a historic overview. Front. Endocrinol. 10, 910 (2019). - DOI

1. Chun, R. F. New perspectives on the  **Vitamin D**  **binding**  protein. Cell Biochem. Funct. 30, 445–456 (2012). - PubMed - DOIing

1. Mendel, C. M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 10, 232–274 (1989). - PubMed - DOI

1. Bikle, D. D. & Schwartz, J.  **Vitamin D**  **binding**  protein, total and free  **Vitamin D** levels in different physiological and pathophysiological conditions. Front. Endocrinol. 10, 317 (2019). - DOI

1. Henderson, C. M. et al. Vitamin D- **binding**  protein deficiency and homozygous deletion of the GC gene. N. Engl. J. Med. 380, 1150–1157 (2019). - PubMed - PMC - DOI

1. Zella, L. A., Shevde, N. K., Hollis, B. W., Cooke, N. E. & Pike, J. W. Vitamin D- **binding**  protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 149, 3656–3667 (2008). - PubMed - PMC - DOI

1. Berg, A. H. et al. Development and analytical validation of a novel bioavailable 25-hydroxy **Vitamin D** assay. PLoS ONE 16, e0254158 (2021). - PubMed - PMC - DOI

1. Denburg, M. R. et al. Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D- **binding**  protein: implications for the assessment of bioavailable  **Vitamin D** concentrations across genotypes. J. Bone Miner. Res. 31, 1128–1136 (2016). - PubMed - DOI

1. Moy, K. A. et al. Genome-wide association study of circulating vitamin D- **binding**  protein. Am. J. Clin. Nutr. 99, 1424–1431 (2014). - PubMed - PMC - DOI

1. Ahn, J. et al. Genome-wide association study of circulating  **Vitamin D** levels. Hum. Mol. Genet. https://doi.org/10.1093/hmg/ddq155 (2010).

1. Revez, J. A. et al. Genome-wide association study identifies 143 loci associated with 25 hydroxy **Vitamin D** concentration. Nat. Commun. 11, 1647 (2020). - PubMed - PMC - DOI

1. Wang, T. J. et al. Common genetic determinants of  **Vitamin D** insufficiency: a genome-wide association study. Lancet 376, 180–188 (2010). - PubMed - PMC - DOI

1. Manousaki, D. et al. Genome-wide association study for  **Vitamin D** Levels reveals 69 independent loci. Am. J. Hum. Genet. 106, 327–337 (2020). - PubMed - PMC - DOI

1. Pludowski, P. et al.  **Vitamin D** effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 12, 976–989 (2013). - PubMed - DOI

1. Holick, M. F. & Chen, T. C.  **Vitamin D** deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87, 1080S–1086S (2008). - PubMed - DOI

1. Holick, M. F.  **Vitamin D** deficiency. N. Engl. J. Med. 357, 266–281 (2007). - PubMed - DOI

1. Eyles, D. W. et al. The association between neonatal  **Vitamin D** status and risk of schizophrenia. Sci. Rep. 8, 17692 (2018). - PubMed - PMC - DOI

1. McGrath, J. J. et al. Neonatal  **Vitamin D** status and risk of schizophrenia: a population-based case-control study. Arch. Gen. Psychiatry 67, 889–894 (2010). - PubMed - DOI

1. Ronaldson, A. et al. Prospective associations between  **Vitamin D** and depression in middle-aged adults: findings from the UK Biobank cohort. Psychol. Med. https://doi.org/10.1017/s0033291720003657 (2020).

1. Cereda, G., Enrico, P., Ciappolino, V., Delvecchio, G. & Brambilla, P. The role of  **Vitamin D** in bipolar disorder: epidemiology and influence on disease activity. J. Affect. Disord. 278, 209–217 (2021). - PubMed - DOI

1. Lee, B. K. et al. Developmental  **Vitamin D** and autism spectrum disorders: findings from the Stockholm Youth Cohort. Mol. Psychiatry 26, 1578–1588 (2021). - PubMed - DOI

1. Sourander, A. et al. Maternal  **Vitamin D** levels during pregnancy and offspring autism spectrum disorder. Biol. Psychiatry 90, 790–797 (2021). - PubMed - PMC - DOI

1. Wang, Z., Ding, R. & Wang, J. The association between  **Vitamin D** status and autism spectrum disorder (ASD): a systematic review and meta-analysis. Nutrients https://doi.org/10.3390/nu13010086 (2020).

1. Vinkhuyzen, A. A. E. et al. Gestational  **Vitamin D** deficiency and autism-related traits: the Generation R Study. Mol. Psychiatry 23, 240–246 (2018). - PubMed - DOI

1. Vinkhuyzen, A. A. E. et al. Gestational  **Vitamin D** deficiency and autism spectrum disorder. BJPsych Open 3, 85–90 (2017). - PubMed - PMC - DOI

1. Sucksdorff, M. et al. Maternal  **Vitamin D** levels and the risk of offspring attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 60, 142–151 e142 (2021). - PubMed - DOI

1. Mossin, M. H. et al. Inverse associations between cord  **Vitamin D** and attention deficit hyperactivity disorder symptoms: a child cohort study. Aust. N. Z. J. Psychiatry 51, 703–710 (2017). - PubMed - DOI

1. Navale, S. S., Mulugeta, A., Zhou, A., Llewellyn, D. J. & Hypponen, E.  **Vitamin D** and brain health: an observational and Mendelian randomization study. Am. J. Clin. Nutr. 116, 531–540 (2022). - PubMed - PMC - DOI

1. Balion, C. et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 79, 1397–1405 (2012). - PubMed - PMC - DOI

1. Xia, K. et al. Dietary-derived essential nutrients and amyotrophic lateral sclerosis: a two-sample Mendelian randomization study. Nutrients https://doi.org/10.3390/nu14050920 (2022).

1. Jiang, X., Ge, T. & Chen, C. Y. The causal role of circulating  **Vitamin D** concentrations in human complex traits and diseases: a large-scale Mendelian randomization study. Sci. Rep. 11, 184 (2021). - PubMed - PMC - DOI

1. Nielsen, N. M. et al. Neonatal  **Vitamin D** status and risk of multiple sclerosis: a population-based case-control study. Neurology 88, 44–51 (2017). - PubMed - PMC - DOI

1. Hahn, J. et al.  **Vitamin D** and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 376, e066452 (2022). - PubMed - PMC - DOI

1. Lemieux, P. et al. Effects of 6-month  **Vitamin D** supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial. Eur. J. Endocrinol. 181, 287–299 (2019). - PubMed - DOI

1. Fletcher, J., Cooper, S. C., Ghosh, S. & Hewison, M. The role of  **Vitamin D** in inflammatory bowel disease: mechanism to management. Nutrients https://doi.org/10.3390/nu11051019 (2019).

1. Zou, J., Thornton, C., Chambers, E. S., Rosser, E. C. & Ciurtin, C. Exploring the evidence for an immunomodulatory role of  **Vitamin D** in juvenile and adult rheumatic disease. Front. Immunol. 11, 616483 (2020). - PubMed - DOI

1. Pedersen, C. B. et al. The iPSYCH2012 case-cohort sample: new directions for unravelling genetic and environmental architectures of severe mental disorders. Mol. Psychiatry 23, 6–14 (2018). - PubMed - DOI

1. Pendergrass, S. A. et al. The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet. Epidemiol. 35, 410–422 (2011). - PubMed - PMC - DOI

1. Amrein, K. et al.  **Vitamin D** deficiency 2.0: an update on the current status worldwide. Eur. J. Clin. Nutr. 74, 1498–1513 (2020). - PubMed - PMC - DOI

1. Keller, A. et al. Concentration of 25-hydroxy **Vitamin D** from neonatal dried blood spots and the relation to gestational age, birth weight and Ponderal Index: the D-tect study. Br. J. Nutr. 119, 1416–1423 (2018). - PubMed - DOI

1. Zaitlen, N. et al. Using extended genealogy to estimate components of heritability for 23 quantitative and dichotomous traits. PLoS Genet. 9, e1003520 (2013). - PubMed - PMC - DOI

1. Weissbrod, O. et al. Functionally informed fine-mapping and polygenic localization of complex trait heritability. Nat. Genet. 52, 1355–1363 (2020). - PubMed - PMC - DOI

1. Institute of Medicine. Dietary Reference Intakes for Calcium and  **Vitamin D** (National Academies Press, 2010).

1. Ashley, B. et al. Placental uptake and metabolism of 25(OH) **Vitamin D** determine its activity within the fetoplacental unit. Elife https://doi.org/10.7554/eLife.71094 (2022).

1. Auburger, G. et al. 12q24 locus association with type 1 diabetes: SH2B3 or ATXN2? World J. Diabetes 5, 316–327 (2014). - PubMed - PMC - DOI

1. Liu, X., Xia, S., Zhang, Z., Wu, H. & Lieberman, J. Channelling inflammation: gasdermins in physiology and disease. Nat. Rev. Drug Discov. 20, 384–405 (2021). - PubMed - PMC - DOI

1. Bjorkhem-Bergman, L., Torefalk, E., Ekstrom, L. & Bergman, P.  **Vitamin D**  **binding**  protein is not affected by high-dose  **Vitamin D** supplementation: a post hoc analysis of a randomised, placebo-controlled study. BMC Res. Notes 11, 619 (2018). - PubMed - PMC - DOI

1. Chun, R. F. et al.  **Vitamin D** and DBP: the free hormone hypothesis revisited. J. Steroid Biochem. Mol. Biol. 144 Pt A, 132–137 (2014). - PubMed - DOI

1. Banerjee, R. R. et al. Very low  **Vitamin D** in a patient with a novel pathogenic variant in the GC gene that encodes vitamin D- **binding**  protein. J. Endocr. Soc. 5, bvab104 (2021). - PubMed - PMC - DOI

1. Jones, K. S. et al. 25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype. J. Clin. Endocrinol. Metab. 99, 3373–3381 (2014). - PubMed - PMC - DOI

1. Karras, S. N., Koufakis, T., Fakhoury, H. & Kotsa, K. Deconvoluting the biological roles of vitamin D- **binding**  protein during pregnancy: a both clinical and theoretical challenge. Front. Endocrinol. 9, 259 (2018). - DOI

1. Zhang, J. Y., Lucey, A. J., Horgan, R., Kenny, L. C. & Kiely, M. Impact of pregnancy on  **Vitamin D** status: a longitudinal study. Br. J. Nutr. 112, 1081–1087 (2014). - PubMed - DOI

1. Harroud, A. & Richards, J. B. Mendelian randomization in multiple sclerosis: a causal role for  **Vitamin D** and obesity? Mult. Scler. 24, 80–85 (2018). - PubMed - DOI

1. Manousaki, D. et al. Low-frequency synonymous coding variation in CYP2R1 has large effects on  **Vitamin D** levels and risk of multiple sclerosis. Am. J. Hum. Genet. 101, 227–238 (2017). - PubMed - PMC - DOI

1. Rhead, B. et al. Mendelian randomization shows a causal effect of low  **Vitamin D** on multiple sclerosis risk. Neurol. Genet. 2, e97 (2016). - PubMed - PMC - DOI

1. Mokry, L. E. et al.  **Vitamin D** and risk of multiple sclerosis: a Mendelian randomization study. PLoS Med. 12, e1001866 (2015). - PubMed - PMC - DOI

1. Deluca, G. C., Kimball, S. M., Kolasinski, J., Ramagopalan, S. V. & Ebers, G. C. The role of  **Vitamin D** in nervous system health and disease. Neuropathol. Appl. Neurobiol. https://doi.org/10.1111/nan.12020 (2013).

1. Cutolo, M., Otsa, K., Uprus, M., Paolino, S. & Seriolo, B.  **Vitamin D** in rheumatoid arthritis. Autoimmun. Rev. 7, 59–64 (2007). - PubMed - DOI

1. Merlino, L. A. et al.  **Vitamin D** intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum. 50, 72–77 (2004). - PubMed - DOI

1. Hewison, M.  **Vitamin D** and the immune system. J. Endocrinol. 132, 173–175 (1992). - PubMed - DOI

1. Xie, Z., Wang, X. & Bikle, D. D. Editorial:  **Vitamin D**  **binding**  protein, total and free  **Vitamin D** levels in different physiological and pathophysiological conditions. Front. Endocrinol. 11, 40 (2020). - DOI

1. Jassil, N. K., Sharma, A., Bikle, D. & Wang, X.  **Vitamin D**  **binding**  protein and 25-hydroxy **Vitamin D** levels: emerging clinical applications. Endocr. Pract. 23, 605–613 (2017). - PubMed - PMC - DOI

1. Nielson, C. M. et al. Free 25-hydroxyvitamin D: impact of  **Vitamin D**  **binding**  protein assays on racial-genotypic associations. J. Clin. Endocrinol. Metab. 101, 2226–2234 (2016). - PubMed - PMC - DOI

1. Powe, C. E. et al. Vitamin D- **binding**  protein and  **Vitamin D** status of black Americans and white Americans. N. Engl. J. Med. 369, 1991–2000 (2013). - PubMed - PMC - DOI

1. Hollis, B. W. & Bikle, D. D. Vitamin D– **binding**  protein and  **Vitamin D** in Blacks and Whites. N. Engl. J. Med. 370, 878–881 (2014).

1. Alzaman, N. S., Dawson-Hughes, B., Nelson, J., D’Alessio, D. & Pittas, A. G.  **Vitamin D** status of black and white Americans and changes in  **Vitamin D** metabolites after varied doses of  **Vitamin D** supplementation. Am. J. Clin. Nutr. 104, 205–214 (2016). - PubMed - PMC - DOI

1. Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021). - PubMed - PMC - DOI

1. Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712–1721 (2021). - PubMed - DOI

1. Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019). - PubMed - DOI

1. Kronenberg, F. et al. Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a). Kidney Int. 54, 1385–1389 (1998). - PubMed - DOI

1. Hall, E. M., Flores, S. R. & De Jesus, V. R. Influence of hematocrit and total-spot volume on performance characteristics of dried blood spots for newborn screening. Int J. Neonatal Screen 1, 69–78 (2015). - PubMed - DOI

1. Thornton, L. M. et al. The anorexia nervosa genetics initiative (ANGI): overview and methods. Contemp. Clin. Trials 74, 61–69 (2018). - PubMed - PMC - DOI

1. Norgaard-Pedersen, B. & Hougaard, D. M. Storage policies and use of the Danish Newborn Screening Biobank. J. Inherit. Metab. Dis. 30, 530–536 (2007). - PubMed - DOI

1. Hollegaard, M. V. et al. Whole genome amplification and genetic analysis after extraction of proteins from dried blood spots. Clin. Chem. 53, 1161–1162 (2007). - PubMed - DOI

1. Boelt, S. G. et al. Sensitive and robust LC-MS/MS assay to quantify 25-hydroxy **Vitamin D** in leftover protein extract from dried blood spots. Int. J. Neonatal Screen. 7, 82 (2021). - PubMed - PMC - DOI

1. Boelt, S. G. et al. A method to correct for the influence of bovine serum albumin-associated  **Vitamin D** metabolites in protein extracts from neonatal dried blood spots. BMC Res. Notes 15, 194 (2022). - PubMed - PMC - DOI

1. Eyles, D. W. et al. The utility of neonatal dried blood spots for the assessment of neonatal  **Vitamin D** status. Paediatr. Perinat. Epidemiol. 24, 303–308 (2010). - PubMed - DOI

1. Eyles, D. et al. A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin. Chim. Acta 403, 145–151 (2009). - PubMed - DOI

1. Kvaskoff, D. et al. Minimizing matrix effects for the accurate quantification of 25-hydroxy **Vitamin D** metabolites in dried blood spots by LC-MS/MS. Clin. Chem. 62, 639–646 (2016). - PubMed - DOI

1. Kvaskoff, D., Ko, P., Simila, H. A. & Eyles, D. W. Distribution of 25-hydroxyvitamin D3 in dried blood spots and implications for its quantitation by tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 901, 47–52 (2012). - DOI

1. Carter, G. D. et al. Hydroxy **Vitamin D** assays: an historical perspective from DEQAS. J. Steroid Biochem. Mol. Biol. 177, 30–35 (2018). - PubMed - DOI

1. McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016). - PubMed - PMC - DOI

1. Lam, M. et al. RICOPILI: rapid imputation for COnsortias PIpeLIne. Bioinformatics 36, 930–933 (2020). - PubMed - DOI

1. Prive, F., Luu, K., Blum, M. G. B., McGrath, J. J. & Vilhjalmsson, B. J. Efficient toolkit implementing best practices for principal component analysis of population genetic data. Bioinformatics 36, 4449–4457 (2020). - PubMed - PMC - DOI

1. Prive, F. et al. Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. Am. J. Hum. Genet. 109, 12–23 (2022). - PubMed - PMC - DOI

1. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011). - PubMed - PMC - DOI

1. Jiang, L. et al. A resource-efficient tool for mixed model association analysis of large-scale data. Nat. Genet. 51, 1749–1755 (2019). - PubMed - DOI

1. Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375 (2012). S361-363. - PubMed - PMC - DOI

1. Zhu, Z. et al. Causal associations between risk factors and common diseases inferred from GWAS summary data. Nat. Commun. 9, 224 (2018). - PubMed - PMC - DOI

1. Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641–3649 (2018). - PubMed - PMC - DOI

1. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015). - PubMed - PMC - DOI

1. Zeng, J. et al. Widespread signatures of natural selection across human complex traits and functional genomic categories. Nat. Commun. 12, 1164 (2021). - PubMed - PMC - DOI

1. Privé, F., Arbel, J. & Vilhjálmsson, B. J. LDpred2: better, faster, stronger. Bioinformatics 36, 5424–5431 (2020). - PubMed - PMC - DOI

1. Zou, Y., Carbonetto, P., Wang, G. & Stephens, M. Fine-mapping from summary data with the “Sum of Single Effects” model. PLoS Genet. 18, e1010299 (2022).

1. Gazal, S. et al. Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat. Genet. 49, 1421–1427 (2017). - PubMed - PMC - DOI

1. McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 122 (2016). - PubMed - PMC - DOI

1. Lloyd-Jones, L. R. et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat. Commun. 10, 5086 (2019). - PubMed - PMC - DOI

1. Lambert, S. A. et al. The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation. Nat. Genet. 53, 420–425 (2021). - PubMed - DOI

1. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015). - PubMed - PMC - DOI

1. Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017). - PubMed - PMC - DOI

1. Trubetskoy, V. et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604, 502–508 (2022). - PubMed - PMC - DOI

1. Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343–352 (2019). - PubMed - PMC - DOI

1. Mullins, N. et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet. 53, 817–829 (2021). - PubMed - PMC - DOI

1. Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019). - PubMed - PMC - DOI

1. Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 51, 63–75 (2019). - PubMed - DOI

1. Marioni, R. E. et al. GWAS on family history of Alzheimer’s disease. Transl. Psychiatry 8, 99 (2018). - PubMed - PMC - DOI

1. Okbay, A. et al. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat. Genet. 54, 437–449 (2022). - PubMed - PMC - DOI

1. International Multiple Sclerosis Genetics, C. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science https://doi.org/10.1126/science.aav7188 (2019).

1. van Rheenen, W. et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 53, 1636–1648 (2021). - PubMed - PMC - DOI

1. Chiou, J. et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature 594, 398–402 (2021). - PubMed - DOI

1. de Lange, K. M. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49, 256–261 (2017). - PubMed - PMC - DOI

1. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014). - PubMed - DOI

1. GTEx Consortium. Genetic effects on gene expression across human tissues. Nature 550, 204 (2017). - PMC - DOI

<!-- ~tc~ (alias(Higher Vitamin D-binding protein in neonates is good – Feb 2023)) ~/tc~ -->